Quintiles Demonstrate Signal Detection Analysis at Pharmacovigilance 2015

LONDON - April 1, 2015 - PRLog -- SMi’s 4th annual Pharmacovigilance, Drug Safety & Risk Management conference will enable attendees to earn CPD points whilst listening to unique insights from an array of industry experts such as PharSafer Associates, Takeda, Daiichi-Sanko Development, Novo Nordisk, Symogen, Pfizer, plus many more.

Highlights will include a spotlight presentation from Margot Stam Moraga, Associate Director of Benefit Risk Management, from Quintiles. Margot will be discussing predictive quality and information sought from signal detection with a focus on disproportionality screening analysis. Guidance will also be given on reducing the impact of the "masking" phenomenon and benefit risk reporting.

Essentially designed for an audience who are looking to learn about the latest developments in pharmacovigilance regulation and best practise in benefit risk assessment, this year’s event will aim to provide delegates with:

1. An understanding of EU’s harmonisation initiatives through MedDRA and Eudravigilance

2. The skills to optimise the outcome of risk assessments and risk minimisation measures

3. A detailed overview of the new PRAC updates for 2015

4. The tools to efficiently bridge preclinical to clinical safety data

For further information or to download a brochure, visit http://www.smi-online.co.uk/pharmaceuticals/uk/pharmacovi...

Pharmacovigilance, Drug Safety and Risk Management
11-12 May 2015
Holiday Inn Regents Park Hotel, London UK
CPD CERTIFIED

---END---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

About Quintiles

Quintiles , a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com. - See more at: http://www.quintiles.com/news/quintiles-and-quest-diagnostics-to-form-joint-venture#sthash.Sohnv0j2.dpuf